TAUNS Laboratories,Inc. (TYO:197A)

Market Cap	53.28B -7.6%
Revenue (ttm)	14.37B -22.9%
Net Income	5.50B -13.0%
EPS	51.08 -13.3%
Shares Out	106.78M
PE Ratio	9.77
Forward PE	16.58
Dividend	29.00 (5.81%)
Ex-Dividend Date	Dec 29, 2026

Volume	181,400
Open	501.00
Previous Close	502.00
Day's Range	498.00 - 504.00
52-Week Range	463.00 - 577.00
Beta	0.68
Analysts	Sell
Price Target	420.00 (-15.83%)
Earnings Date	Nov 12, 2026

About TAUNS Laboratories,Inc.

TAUNS Laboratories,Inc. engages in the development, manufacture, export/import, and sale of in vitro diagnostics and research reagents, and its intermediates in Japan and internationally. It also offers medical physicochemical measuring equipment, industrial measuring equipment, and medical devices; and contract research services. The company was founded in 1987 and is headquartered in Izunokuni, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 218
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 197A

Financial Performance

In fiscal year 2026, TAUNS Laboratories,Inc.'s revenue was 14.37 billion, a decrease of -22.86% compared to the previous year's 18.63 billion. Earnings were 5.50 billion, a decrease of -12.99%.

Analyst Summary

According to 2 analysts, the average rating for 197A stock is "Sell." The 12-month stock price target is ¥420, which is a decrease of -15.83% from the latest price.

Price Target

¥420

(-15.83% downside)

Analyst Consensus: Sell

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 23, 2026

Data Sources Report a data error